Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00571662 · OUTCOME

Toxicity for the Combination of Pentostatin and Low Dose Total Body Irradiation (TBI)

Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant · Source last updated 2023-10-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
Conditioning regimen to count recovery (D + 28 post transplant)

Groups in this outcome

Cohort I

Pentostatin to be administered intravenously on days -10, -9, and -8 at a dose of 4mg/m2/day

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Cohort I68

Reported measurements

Absolute neutrophil count < 500/mm^3
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cohort I40Not reportedNot reportedNot reportedNot reported
platelet count < 20,000/mm^3
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cohort I29Not reportedNot reportedNot reportedNot reported
Grade 3 or 4 Fever
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cohort I2Not reportedNot reportedNot reportedNot reported
Grade 3 or 4 hypokalemia
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cohort I1Not reportedNot reportedNot reportedNot reported
Grade 3 or 4 bacteremia
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cohort I2Not reportedNot reportedNot reportedNot reported
Grade 3 or 4 infection
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cohort I6Not reportedNot reportedNot reportedNot reported
Grade 3 or 4 renal toxicity
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cohort I1Not reportedNot reportedNot reportedNot reported
Grade 3 or 4 thromboembolism
Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Cohort I1Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        40
    title
    Absolute neutrophil count < 500/mm^3
  2. categories
    1. measurements
      1. group Id
        OG000
        value
        29
    title
    platelet count < 20,000/mm^3
  3. categories
    1. measurements
      1. group Id
        OG000
        value
        2
    title
    Grade 3 or 4 Fever
  4. categories
    1. measurements
      1. group Id
        OG000
        value
        1
    title
    Grade 3 or 4 hypokalemia
  5. categories
    1. measurements
      1. group Id
        OG000
        value
        2
    title
    Grade 3 or 4 bacteremia
  6. categories
    1. measurements
      1. group Id
        OG000
        value
        6
    title
    Grade 3 or 4 infection
  7. categories
    1. measurements
      1. group Id
        OG000
        value
        1
    title
    Grade 3 or 4 renal toxicity
  8. categories
    1. measurements
      1. group Id
        OG000
        value
        1
    title
    Grade 3 or 4 thromboembolism
denoms
  1. counts
    1. group Id
      OG000
      value
      68
    units
    Participants
groups
  1. description
    Pentostatin to be administered intravenously on days -10, -9, and -8 at a dose of 4mg/m2/day
    id
    OG000
    title
    Cohort I
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
Conditioning regimen to count recovery (D + 28 post transplant)
title
Toxicity for the Combination of Pentostatin and Low Dose Total Body Irradiation (TBI)
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice